GMP Plasmid DNA Manufacturing Market, By Product (Plasmid DNA, Viral Vectors and Non-viral), By Application, By Type, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV5922
|
Published Date
August 2026
|
Pages
294
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
GMP Plasmid DNA Manufacturing Market size was valued at US$ 278.65 Million in 2025, expanding at a CAGR of 9.5% from 2026 to 2033.
GMP Plasmid DNA Manufacturing is the creation of plasmid DNA in accordance with good manufacturing practice to provide consistent production, control and documentation for clinical trial and commercial biopharmaceutical applications. The procedure generally includes plasmid design/preparation, microbial fermentation, plasmid extraction, purification, concentration, sterile filtration and quality-controlled testing. GMP manufacturing involves complete control of materials, environment, equipment, personnel and process to prevent contamination and to ensure quality, purity, identity, potency and safety of the finished product. GMP-grade plasmid DNA is frequently employed as a key starting material or pharmaceutical ingredient in gene treatments, DNA vaccines, cell therapies and other biotherapeutics.
GMP Plasmid DNA Manufacturing Market- Market Dynamics
Rising number of clinical trials to propel market demand
The increasing number of clinical trials for gene therapies, cell therapies, vaccines and other advanced medicines are driving demand for GMP plasmid DNA as clinical-stage developers need high-quality, regulatory-compliant DNA for viral-vector synthesis and other therapeutic uses. The product launches in 2025 are an example of this tendency. Specifically, in April 2025, ProBio initiated its GMP plasmid DNA manufacturing service at its Hopewell, New Jersey plant, offering clinical-grade plasmid DNA with a targeted delivery timetable of about three months from cell bank to batch release. The company has specifically designed the service to accelerate clinical programs for gene and cell therapies.
Similarly, Aldevron launched its small-scale GMP (ssGMP) plasmid DNA service in July 2025, providing 1 mg to 500 mg quantities that are ideal for early-phase clinical programs such as small patient cohort trials, AAV and lentiviral vector manufacturing, CRISPR-based editing of genes, and transposon therapies. These launches are examples of how the increasing activity in clinical trials is increasing the demand not only for large scale commercial GMP plasmid production but also for flexible smaller volume GMP manufacturing, thus driving the growth of the GMP plasmid DNA manufacturing business.
GMP Plasmid DNA Manufacturing Market- Segmentation Analysis:
The Global GMP Plasmid DNA Manufacturing Market is segmented on the basis of Product, Application, Type, and Region.
The market is divided into seven categories based on product: Plasmid DNA, Viral Vectors, Non-viral, Electroporation, Lipid/polymer, Nanoparticles and Others. The Plasmid DNA segment dominates the market. The growth is assisted by the rising number of advanced-therapy programs, which are entering clinical and commercial manufacturing from research and preclinical stages. The companies involved are looking to scale their production, while ensuring the quality of the nucleic acid-based products. Thus, the rising number of pharmaceutical and biotech firms, which are looking to manufacture more high-purity, GMP-grade plasmid DNA, also contributes to the growth of this market.
Moreover, the expansion of viral-vector manufacturing, including such platforms as AAV or lentiviral, is further driving the need for plasmid DNA, as they are often used as part of the process. One more factor which supports the growth of the plasmid DNA manufacturing segment is the companies’ investments in the research and development of various fields. For instance, one of the leading manufacturers of plasmid DNA, Aldevron, has announced that it has manufactured more than 165,000 plasmid lots, of which approximately 5,000 are clinical-grade lots. Altogether, they support cell, gene, and mRNA therapy programs, which are either in the clinical trial phases or have been commercialized. Therefore, this trend is expected to support the growth of the GMP plasmid DNA manufacturing market. These launches exemplify that the growing activity in clinical trials is raising the demand not only for large-scale commercial GMP plasmid production but also for flexible, smaller-volume GMP manufacturing, thus fueling the growth of the GMP plasmid DNA manufacturing industry.
The market is divided into four categories based on application: DNA Vaccines, Immunotherapy, Gene Therapy and Others. The DNA Vaccines dominate the market and is likely to maintain its dominance during the forecast period. The main reason behind the growth of the market is the increasing research and clinical development of DNA vaccines, especially for infectious diseases, and cancer. As DNA-vaccine candidates are advancing toward clinical trials, manufacturers are in need of GMP-grade plasmid DNA with high purity, consistency, and regulatory compliance, which increases the demand for specialized plasmid manufacturing services. The research on DNA-plasmid vaccine development is a significant factor supporting the overall plasmid DNA manufacturing market.
GMP Plasmid DNA Manufacturing Market- Geographical Insights
North America holds a prominent market share. Government investment is playing a crucial role in backing such growth. In FY2025, the U.S. National Institutes of Health (NIH) reported a total of about US$48.5 billion. In FY2025, NIH reported US$35.3 billion for competing and noncompeting extramural research awards. These grants help sustain the biomedical research ecosystem that supplies the source of advanced-therapy candidates and clinical programs, which indirectly drives demand for GMP plasmid DNA as medicines enter the clinical development stage.
Government funding also assists advanced cell therapy producers by supporting biomanufacturing infrastructure. The U.S. Department of Commerce announced the Manufacturing USA network financing of US$ 37 million by NIST, including the US$ 14 million yearly allocation for the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The Department of Energy (DOE) sponsored Advanced Cell Therapy manufacturers by fostering domestic biomanufacturing R&D and scale-up activities.
The demand is growing, and industry participants are increasing the investment in the construction of production facilities. For instance, ProBio announced in June 2025 that it would build a 128,000-square-foot GMP plasmid DNA and viral-vector production facility in Hopewell, N.J. The company hopes to satisfy the growing demand for viral vectors by boosting the capacities in the production of cell and gene therapy manufacturers. Hence, the investments in GMP manufacturing facilities along with increasing R&D spending in the biopharmaceutical sector, government-sponsored biomedical research, and augmented clinical pipeline would drive the revenue growth of the GMP plasmid DNA manufacturing market in North America.
US GMP Plasmid DNA Manufacturing Market- Country Insights
The US Capture the largest market share. The major driver driving this growth is the increasing collaborations among the key players in the market, which is increasing the utilization of plasmid DNA for downstream therapeutic manufacture. In May 2025, Wacker Biotech US and Expression Manufacturing forged a strategic relationship to fast-track the development and manufacturing of lentiviral-based gene and cell therapies. Wacker brings their PLASMITEC® plasmid DNA platform that features >90% supercoiled pDNA while Expression Manufacturing offers the viral-vector technology. The agreement provides a complete solution from GMP plasmid starting materials to viral-vector production and expands the potential market for plasmid DNA as more gene and cell therapy studies are initiated.
GMP Plasmid DNA Manufacturing Market- Competitive Landscape:
The GMP plasmid DNA manufacturing market is moderately consolidated and competitive, with key CDMOs and plasmid-specific manufacturers vying to secure the majority of the demand by capitalizing on capabilities such as GMP manufacturing capacity, advanced purification technologies, regulatory know-how, turnaround time, scalability, and an ability to offer integrated cell- and gene-therapy services. The key market participants include Aldevron (Danaher), Charles River Laboratories, Thermo Fisher Scientific, Lonza, GenScript ProBio, VGXI, Catalent, AGC Biologics, Kaneka Eurogentec, PlasmidFactory, and WuXi Advanced Therapies. The competition is expected to intensify on the back of an increasing number of players offering end-to-end manufacturing services, which incorporate both plasmid DNA and viral-vector manufacturing and provide comprehensive cell- and gene-therapy solutions to meet the demands of customers at various stages of research and commercialization.
Recent Developments:
- In August 2025, Bionova Scientific (Bionova), a biologics contract development and manufacturing organization (CDMO) and a subsidiary of Asahi Kasei, announced that it has opened a new 10,000-square-foot development and production facility for plasmid DNA (pDNA) in The Woodlands, Texas. The launch of this new facility marks a strategic expansion for the pharmaceutical industry, strengthening the US supply chain for advanced therapeutics. The site will design, develop, and produce research-grade pDNA materials to support the growing cell and gene therapy (CGT) sector.
- In August 2025, WACKER and Gearbox Biosciences announced strategic collaboration to advance plasmid DNA manufacturing technologies. The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GMP PLASMID DNA MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Weisman Biomanufacturing
- Wuxi Advanced Therapies
- Rescript Probe
- Cobra Bio
- Charles River
- Thermo Fisher Scientific
- Bioscience
- Lake Pharma
- Alderton
- Kaneka Neurogenetic S.A.
- Catalent Biologics
- Neurogenetic
- Nature Technology Corporation
- Plasmid Factory
- VGXI, Inc.
- Vector Builder
- Delphi Genetics
- Esko Aster
- Bionian
- Creative Biolabs
- Cognate Bio Services
- Patheon
- Vilene Biosciences
- Others
GLOBAL GMP PLASMID DNA MANUFACTURING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Plasmid DNA
- Viral Vectors
- Retroviral
- Adenoviral
- Lentiviral
- Adeno-Associated
- Others
- Non-viral
- Electroporation
- Lipid/polymer
- Nanoparticles
- Others
GLOBAL GMP PLASMID DNA MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- DNA Vaccines
- Immunotherapy
- Gene Therapy
- Others
GLOBAL GMP PLASMID DNA MANUFACTURING MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
GLOBAL GMP PLASMID DNA MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENTS
1. GMP Plasmid DNA Manufacturing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. GMP Plasmid DNA Manufacturing Market Snippet by Product
2.1.2. GMP Plasmid DNA Manufacturing Market Snippet by Application
2.1.3. GMP Plasmid DNA Manufacturing Market Snippet by Type
2.1.4. GMP Plasmid DNA Manufacturing Market Snippet by Country
2.1.5. GMP Plasmid DNA Manufacturing Market Snippet by Region
2.2. Competitive Insights
3. GMP Plasmid DNA Manufacturing Key Market Trends
3.1. GMP Plasmid DNA Manufacturing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. GMP Plasmid DNA Manufacturing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. GMP Plasmid DNA Manufacturing Market Opportunities
3.4. GMP Plasmid DNA Manufacturing Market Future Trends
4. GMP Plasmid DNA Manufacturing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. GMP Plasmid DNA Manufacturing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. GMP Plasmid DNA Manufacturing Market Landscape
6.1. GMP Plasmid DNA Manufacturing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. GMP Plasmid DNA Manufacturing Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
7.1.2. Plasmid DNA
7.1.3. Viral Vectors
7.1.3.1. Retroviral
7.1.3.2. Adenoviral
7.1.3.3. Lentiviral
7.1.3.4. Adeno-Associated
7.1.3.5. Others
7.1.4. Non-viral
7.1.5. Electroporation
7.1.6. Lipid/polymer
7.1.7. Nanoparticles
7.1.8. Others
8. GMP Plasmid DNA Manufacturing Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. DNA Vaccines
8.1.3. Immunotherapy
8.1.4. Gene Therapy
8.1.5. Others
9. GMP Plasmid DNA Manufacturing Market – By Type
9.1. Overview
9.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
9.1.2. Pre-Clinical Therapeutics
9.1.3. Clinical Therapeutics
9.1.4. Marketed Therapeutics
10. GMP Plasmid DNA Manufacturing Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2. North America
10.2.1. Overview
10.2.2. GMP Plasmid DNA Manufacturing Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.6. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. GMP Plasmid DNA Manufacturing Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.9.5. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.16. Denmark
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.16.3. Denmark Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.16.5. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.17. Rest of Europe
10.3.17.1. Overview
10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.17.5. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. GMP Plasmid DNA Manufacturing Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.6. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.7.5. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.8.5. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.15. Taiwan
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.15.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.15.5. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.16. Vietnam
10.4.16.1. Overview
10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.16.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.16.5. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.17. Rest of APAC
10.4.17.1. Overview
10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.17.5. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. GMP Plasmid DNA Manufacturing Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. GMP Plasmid DNA Manufacturing Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.6. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.13. Iran
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.13.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.13.5. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.14. Qatar
10.6.14.1. Overview
10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.14.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.14.5. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.15. Rest of MEA
10.6.15.1. Overview
10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.15.5. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- GMP Plasmid DNA Manufacturing Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Weisman Biomanufacturing
11.2.2. Wuxi Advanced Therapies
11.2.3. Rescript Probe
11.2.4. Cobra Bio
11.2.5. Charles River
11.2.6. Thermo Fisher Scientific
11.2.7. Bioscience
11.2.8. Lake Pharma
11.2.9. Alderton
11.2.10. Kaneka Neurogenetic S.A.
11.2.11. Catalent Biologics
11.2.12. Neurogenetic
11.2.13. Nature Technology Corporation
11.2.14. Plasmid Factory
11.2.15. VGXI, Inc.
11.2.16. Vector Builder
11.2.17. Delphi Genetics
11.2.18. Esko Aster
11.2.19. Bionian
11.2.20. Creative Biolabs
11.2.21. Cognate Bio Services
11.2.22. Patheon
11.2.23. Vilene Biosciences
11.2.24. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GMP PLASMID DNA MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Weisman Biomanufacturing
- Wuxi Advanced Therapies
- Rescript Probe
- Cobra Bio
- Charles River
- Thermo Fisher Scientific
- Bioscience
- Lake Pharma
- Alderton
- Kaneka Neurogenetic S.A.
- Catalent Biologics
- Neurogenetic
- Nature Technology Corporation
- Plasmid Factory
- VGXI, Inc.
- Vector Builder
- Delphi Genetics
- Esko Aster
- Bionian
- Creative Biolabs
- Cognate Bio Services
- Patheon
- Vilene Biosciences
- Others
GLOBAL GMP PLASMID DNA MANUFACTURING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Plasmid DNA
- Viral Vectors
- Retroviral
- Adenoviral
- Lentiviral
- Adeno-Associated
- Others
- Non-viral
- Electroporation
- Lipid/polymer
- Nanoparticles
- Others
GLOBAL GMP PLASMID DNA MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- DNA Vaccines
- Immunotherapy
- Gene Therapy
- Others
GLOBAL GMP PLASMID DNA MANUFACTURING MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
GLOBAL GMP PLASMID DNA MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
